Published in Medical Letter on the CDC and FDA, September 8th, 2002
The team, led by Suzanne Emerson, PhD, also has discovered that deliberately weakened HAV can quickly revert to its naturally occurring, infection-causing form. Published in the September 1, 2002, issue of the Journal of Virology, these findings indicate that making an improved vaccine for HAV will be a very difficult task.
"As sanitation improves in developing countries, there will be an increased need for inexpensive and easy-to-administer vaccines to prevent hepatitis A,...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Letter on the CDC and FDA
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.